Four Seasons Education Reports First Half of Fiscal Year 2026 Unaudited Financial Results SHANGHAI, Dec. 2, 2025 /PRNewswire/ — Four Seasons Education (Cayman) Inc. ("Four…CISION PRNewswireDecember 2, 2025
Finloop Launches Asia's First Comprehensive Technical Solution for Japanese Stock Tokenization HONG KONG, Dec. 2, 2025 /PRNewswire/ — Finloop Finance Technology Holding Limited…CISION PRNewswireDecember 2, 2025
DPC Dash- Domino's Pizza China Wins Fifth Seven-Star Award HONG KONG, Dec. 2, 2025 /PRNewswire/ — DPC Dash – Domino’s Pizza…CISION PRNewswireDecember 2, 2025
Press ReleaseKuCoin Institutional and CryptoStruct Partner to Advance Institutional Algorithmic Trading Infrastructure PROVIDENCIALES, Turks and Caicos Islands, Dec. 2, 2025 /PRNewswire/ — KuCoin Institutional,…CISION PRNewswireDecember 2, 2025
New TayaGel® Modus expands Jungbunzlauer's texturant portfolio – A new era in gellan gum innovation delivers crystal-clear gels with…CISION PRNewswireDecember 2, 2025
Press ReleaseNeusoft Medical Systems Unveils World's First 8cm Wide-Coverage Photon-Counting CT and Other Premium Innovations at RSNA 2025 CHICAGO, Dec. 2, 2025 /PRNewswire/ — Neusoft Medical Systems Co., Ltd. ("Neusoft Medical"),…CISION PRNewswireDecember 2, 2025
Press ReleaseCango Inc. Reports Third Quarter 2025 Unaudited Financial Results DALLAS, Dec. 2, 2025 /PRNewswire/ — On December 1, Cango Inc. (NYSE:…CISION PRNewswireDecember 2, 2025
Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ — Antengene Corporation Limited ("Antengene",…CISION PRNewswireDecember 2, 2025